Home › Pulmonary Hypertension › NCT06751082

Real World Observational Study of Sotatercept for Pulmonary Hypertension

Sotatercept Pulmonary Hypertension Observational Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic.

Exclusion Criteria:

* Adults lacking capacity to consent

About the study

The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.

Sponsor: Mayo Clinic · Participants: 120 · Started: Jan 20, 2025

Contact the study team

• Hayden Halbach, M.B.A. · Phone: 507-255-2648
• Louise Durst, R.N. · Phone: 507-284-1838

Official record on ClinicalTrials.gov — NCT06751082

Locations in the U.S.

Conditions

• Pulmonary Hypertension

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.